Purpose/Objective: Organ sparing treatment is gradually becoming an option for patients with locally advanced rectal cancer (LARC) with good clinical response after neo-adjuvant chemoradiation (CRT). However, patient selection for organ sparing treatment is challenging and there is no standard of care restaging procedure after CRT. Functional MR imaging, diffusion weighted MRI (DW-MRI) and dynamic contrast enhanced MRI (DCE-MRI) showed promising results in earlier studies. In this study, we assessed the value of combined T2 weighted MRI (T2w) volumetry, DW-MRI and DCE-MRI for pathological response prediction after neo-adjuvant CRT in patients with LARC. Materials and Methods: Patients received MRI with DW-MRI and DCE-MRI sequences before start of CRT and before surgery. After surgery, the tumor regression grade (TRG) was obtained based on the score by Mandard et al. Pathological complete responders (pCR, Mandard 1) were compared with non-pCR patients. Besides, patients with a good response, GR (Mandard 1+2) were compared with patients with a non-GR. Results: From the 55 patients analyzed in the study, six showed a pCR (10.9%) and 10 had a GR (18.6%). Favorable responders had a larger decrease in tumor volume, a larger increase in Apparent Diffusion Coefficient (ADC) values and a larger decrease in Ktrans compared to non-responders. ADC change showed the best accuracy for diagnoses of pCR. For GR, the model including ADC change and volume change showed the best diagnostic performance. Inclusion of Ktrans change did not increase the diagnostic values for pathological favorable response.
: Diagnostic values for the diagnosis of pathological complete response (pCR) and pathological good response (GR) for the different models. In the individual parameter models the optimal cut-off values for Δvolume, ΔADC and ΔKtrans were -74%, +44% and -32%, respectively. Abbreviation: ADC = apparent diffusion coefficient, AUC = area under the receiver operating curve, PPV = positive predictive value and NPV = negative predictive value.
Figure 1: receiver operating characteristic (ROC) curves for models with the best diagnostic accuracy for pathological complete reseponse (pCR, left) and pathological good response (GR, right) . Conclusions: This explorative study showed that ADC decrease is a promising diagnostic tool for pCR and the combination of ADC and volume decrease for GR in patients with LARC after neo-adjuvant CRT. Ktrans change showed no additional value. These results justify further research in a larger prospective study with DW-MRI and tumor volumetry.
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Robustness of three stoichiometric CT-calibration parameterizations used in proton therapy J. Odén 1 , J. Zimmerman 1 , G. Poludniowski 1 1 Karolinska University Hospital, Department of Medical Physics, Stockholm, Sweden Purpose/Objective: The use of a stoichiometric CTcalibration has become the standard method for converting CT-numbers to relative proton stopping-power-ratios (SPR) worldwide. However, several different parameterizations for the calibration have been published and the aim of this project is to assess accuracy and robustness of the CTcalibration for three different parameterizations. Materials and Methods: Phantom model 062M from CIRS (Norfolk, VA, USA) with a fixed distribution of inserts with known mass density and elemental composition was scanned daily over a period of two months with a 120 kVp clinical protocol on a Siemens Definition AS+ to determine the variation of the CT-numbers. Repeated calibration scans with the inserts positioned centrally in a homogenous phantom, one by one, were performed to determine stable mean CTnumbers.Three published stoichiometric parameterizations using 1, 2 or 3 fitting parameters were evaluated by simulating random changes in the measured mean CTnumbers based on the measured variation. CT-numbers for 72 theoretical tissue compositions were then calculated for each simulation. The resulting mean values and SD were plotted against their Bethe-Bloch calculated SPR for 100 MeV protons. Finally the mean-calibration curve was determined for each parameterization using piecewise connection of weighted linear regressions within each tissue group. Results: The measured SD for the inserts was 1-5 HU (mean SD 2.7 HU). 10000 simulations of the stoichiometric calibration were performed for each parameterization, using a normal distribution with the measured mean values and a standard deviation of 3 HU for the inserts. The resulting RMSE was similar between the three methods for all simulations. For each method the resulting mean-calibration curve is plotted in Figure 1a together with the mean CT-number and SD (horizontal error bars) for the 72 theoretical tissues. The curves from the methods using 2 and 3 fitting parameters are more or less inseparable throughout the whole CT-range, whereas the 1-fitting parameter method differ somewhat in the dense bone region. The largest disagreement is 18 HU for cortical bone (#72). This corresponds to 0.6% difference in SPR for a HU of 1200. The SD of the calculated CT-numbers is presented separately in Figure 1b . The method using 3 fitting parameters have significantly larger SD compared to the other two methods, especially for bony tissues.
Conclusions:
A stoichiometric calibration is feasible using all three parameterizations. The resulting mean-calibration curves are similar for all three methods. However, when introducing a random variation in the measured CT-numbers, as is manifest daily from scan to scan, the parameterization using 3 fitting parameters demonstrates significantly larger variation in the calculated CT-numbers of the theoretical tissues. The impact of this to the uncertainty in the proton ranges in human tissues will be studied further. Purpose/Objective: Detailed knowledge of the esophageal tumor boundary is currently lacking. This uncertainty leads to large margins and risk of geographic miss during irradiation. Optical coherence tomography (OCT) is a minimally invasive and high resolution (1-10 µm) imaging technique that obtains cross-sectional images of tissue based on the backscattering of light. OCT has a great potential for esophageal cancer, as cylindrical probes exist that can scan the surface using a single rotating optical fiber. Fiducial markers have been successfully applied in a variety of treatment sites to provide guidance during tumor delineation and setup verification. Recently, we successfully placed markers at the proximal and distal tumor borders in esophageal cancer patients. Integration of the OCT with the CT used for treatment planning is an unsolved problem. Visibility of markers on OCT is crucial for an accurate registration of the OCT with the planning CT. This study aimed to investigate the visibility on OCT of two commercially available gold markers at 3 different depths; enabling registration with CT. Materials and Methods: OCT is similar to ultrasound, however, it uses near infrared light instead of sound. While OCT has a 10 times higher resolution than ultrasound, it suffers from a limited penetration depth in the range of 2-3 mm. We designed and manufactured a dedicated esophageal phantom, in which 3 different scattering materials represent esophageal wall layers (figure 1.A). Visicoil and Gold Anchor markers were implanted at different depths (≤0.2 mm, 0.6 mm, and 1.2 mm) and imaged using an endoscopic OCT imaging system (Nvision VLE Imaging System, NinePoint Medical, Inc.) . Further, to evaluate whether in current clinical practice the fiducial markers are placed within the OCT visualization range; we retrospectively measured the distance between the implanted gold markers and the inner wall of the esophagus on the planning CT of 7 patients who underwent endoscopy-guided marker implantation. Additionally, we manually coregistered the phantom OCT and CT images with use of the markers. Results: Figure 1 .B shows that both types of gold markers are visible on OCT at all tested depths. Different scattering materials are visible on OCT. CT measurements from 7 patients (9 fiducial markers) yield that on average the markers were implanted at a depth of 1.7 mm (range: 0.7-6.3 mm) in the esophageal wall (table 1). For the 9 fiducial markers included in our retrospective analysis, 89% of the markers were placed at depths ≤2.0 mm and 44% were placed at depths ≤1.2 mm. Manual coregistration based on 2 markers was feasible (figure 1.C.).
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Conclusions:
We have designed and manufactured a dedicated esophageal phantom, enabling the study of the visibility of two types of gold markers at different depths on OCT. The results indicate that both Visicoil and Gold Anchor markers are visible on OCT at depths ≤1.2 mm. Also, based on CT measurements, the majority of the markers in current clinical practice are already placed within the OCT visualization range.
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